{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,27]],"date-time":"2026-01-27T10:03:08Z","timestamp":1769508188873,"version":"3.49.0"},"reference-count":33,"publisher":"Elsevier BV","issue":"38","license":[{"start":{"date-parts":[[2015,9,1]],"date-time":"2015-09-01T00:00:00Z","timestamp":1441065600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Vaccine"],"published-print":{"date-parts":[[2015,9]]},"DOI":"10.1016\/j.vaccine.2015.06.097","type":"journal-article","created":{"date-parts":[[2015,7,5]],"date-time":"2015-07-05T12:24:53Z","timestamp":1436099093000},"page":"4994-4999","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":18,"title":["Current status of Bacille Calmette Gu\u00e9rin (BCG) immunisation in Europe \u2013 A ptbnet survey and review of current guidelines"],"prefix":"10.1016","volume":"33","author":[{"given":"Alexa","family":"Dierig","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marc","family":"Tebruegge","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Uros","family":"Krivec","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ulrich","family":"Heininger","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nicole","family":"Ritz","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"September","key":"10.1016\/j.vaccine.2015.06.097_bib0170","first-page":"w14000","article-title":"Novel concepts in the epidemiology, diagnosis and prevention of childhood tuberculosis","volume":"144","author":"Ritz","year":"2014","journal-title":"Swiss Med Wkly"},{"issue":"37 (Sep)","key":"10.1016\/j.vaccine.2015.06.097_bib0175","first-page":"1","article-title":"Systematic review and meta-analysis of the current evidence on the duration of protection by bacillus Calmette-Guerin vaccination against tuberculosis","volume":"17","author":"Abubakar","year":"2013","journal-title":"Health Technol Assess"},{"issue":"9517 (Apr 8)","key":"10.1016\/j.vaccine.2015.06.097_bib0180","doi-asserted-by":"crossref","first-page":"1173","DOI":"10.1016\/S0140-6736(06)68507-3","article-title":"Effect of BCG vaccination on childhood tuberculous meningitis and miliary tuberculosis worldwide: a meta-analysis and assessment of cost-effectiveness","volume":"367","author":"Trunz","year":"2006","journal-title":"Lancet"},{"key":"10.1016\/j.vaccine.2015.06.097_bib0185","unstructured":"World Health Organization. BCG vaccine: WHO position paper. Weekly Epidemiological Record 2004;4:27\u201338."},{"key":"10.1016\/j.vaccine.2015.06.097_bib0190","unstructured":"World Health Organization Reported estimates of BCG coverage. 2014 29.10.14 [cited; Available from: \u3008http:\/\/apps.who.int\/immunization_monitoring\/globalsummary\/timeseries\/tscoveragebcg.html\u3009."},{"key":"10.1016\/j.vaccine.2015.06.097_bib0195","unstructured":"World Health Organization Reported estimates of BCG coverage. 2014."},{"issue":"1","key":"10.1016\/j.vaccine.2015.06.097_bib0200","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1183\/09031936.00113413","article-title":"Bacille Calmette-Guerin vaccination: the current situation in Europe","volume":"43","author":"Dara","year":"2014","journal-title":"Eur Respir J"},{"issue":"3","key":"10.1016\/j.vaccine.2015.06.097_bib0205","doi-asserted-by":"crossref","first-page":"6","DOI":"10.2807\/esm.11.03.00604-en","article-title":"European survey of BCG vaccination policies and surveillance in children, 2005","volume":"11","author":"Infuso","year":"2006","journal-title":"Euro Surveill"},{"key":"10.1016\/j.vaccine.2015.06.097_bib0210","unstructured":"A. Zwerling, M. Behr, T. Brewer, D. Menzies and M. Pai, BCG World Atlas. [cited 18.12.08]; Available from: \u3008http:\/\/www.bcgatlas.org\/index.php\u3009."},{"issue":"3 (Mar)","key":"10.1016\/j.vaccine.2015.06.097_bib0215","doi-asserted-by":"crossref","first-page":"e1001012","DOI":"10.1371\/journal.pmed.1001012","article-title":"The BCG World Atlas: a database of global BCG vaccination policies and practices","volume":"8","author":"Zwerling","year":"2011","journal-title":"PLoS Med."},{"issue":"6 (Jun)","key":"10.1016\/j.vaccine.2015.06.097_bib0220","doi-asserted-by":"crossref","first-page":"588","DOI":"10.1136\/thoraxjnl-2012-202824","article-title":"Inclusion of latent tuberculosis infection as a separate entity into the international classification of diseases","volume":"68","author":"Tebruegge","year":"2013","journal-title":"Thorax"},{"issue":"9959 (Dec 6)","key":"10.1016\/j.vaccine.2015.06.097_bib0225","doi-asserted-by":"crossref","first-page":"2026","DOI":"10.1016\/S0140-6736(14)62335-7","article-title":"Shortage of purified protein derivative for tuberculosis testing","volume":"384","author":"Tebruegge","year":"2014","journal-title":"Lancet"},{"issue":"6","key":"10.1016\/j.vaccine.2015.06.097_bib0230","doi-asserted-by":"crossref","first-page":"e99129","DOI":"10.1371\/journal.pone.0099129","article-title":"Availability and use of molecular microbiological and immunological tests for the diagnosis of tuberculosis in Europe","volume":"9","author":"Tebruegge","year":"2014","journal-title":"PloS One"},{"key":"10.1016\/j.vaccine.2015.06.097_bib0235","unstructured":"European Centre for Disease Prevention and Control. Recommended immunisations for tuberculosis [cited 11.03.15]; Available from: \u3008http:\/\/vaccine-schedule.ecdc.europa.eu\/Pages\/Scheduler.aspx\u3009."},{"key":"10.1016\/j.vaccine.2015.06.097_bib0240","unstructured":"World Health Organization WHO vaccine-preventable diseases: monitoring system. 2014 [cited 11.03.15]; Available from: \u3008http:\/\/apps.who.int\/immunization_monitoring\/globalsummary\/schedules\u3009."},{"issue":"5 (Aug)","key":"10.1016\/j.vaccine.2015.06.097_bib0245","doi-asserted-by":"crossref","first-page":"821","DOI":"10.1111\/j.1574-6976.2008.00118.x","article-title":"Influence of BCG vaccine strain on the immune response and protection against tuberculosis","volume":"32","author":"Ritz","year":"2008","journal-title":"FEMS Microbiol Rev"},{"issue":"4 (Jul)","key":"10.1016\/j.vaccine.2015.06.097_bib0250","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1016\/j.tube.2009.03.002","article-title":"Mapping the global use of different BCG vaccine strains","volume":"89","author":"Ritz","year":"2009","journal-title":"Tuberculosis (Edinb)"},{"issue":"January (2)","key":"10.1016\/j.vaccine.2015.06.097_bib0255","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1164\/rccm.201104-0714OC","article-title":"The influence of BCG vaccine strain on the immune response against tuberculosis: a randomised trial","volume":"182","author":"Ritz","year":"2012","journal-title":"Am J Respir Crit Care Med"},{"issue":"7","key":"10.1016\/j.vaccine.2015.06.097_bib0260","doi-asserted-by":"crossref","first-page":"e37535","DOI":"10.1371\/journal.pone.0037535","article-title":"A comparative analysis of polyfunctional T cells and secreted cytokines induced by Bacille Calmette-Guerin immunisation in children and adults","volume":"7","author":"Ritz","year":"2012","journal-title":"PLoS One"},{"issue":"7 (Apr 1)","key":"10.1016\/j.vaccine.2015.06.097_bib0265","doi-asserted-by":"crossref","first-page":"779","DOI":"10.1164\/ajrccm.187.7.779","article-title":"Reply: Bacille Calmette-Guerin vaccine: innate immunity and nonspecific effects","volume":"187","author":"Ritz","year":"2013","journal-title":"Am J Respir Crit Care Med"},{"issue":"3","key":"10.1016\/j.vaccine.2015.06.097_bib0270","doi-asserted-by":"crossref","first-page":"e32567","DOI":"10.1371\/journal.pone.0032567","article-title":"Comparative tuberculosis (TB) prevention effectiveness in children of Bacillus Calmette-Guerin (BCG) vaccines from different sources, Kazakhstan","volume":"7","author":"Favorov","year":"2012","journal-title":"PLoS One"},{"issue":"1 (Jan)","key":"10.1016\/j.vaccine.2015.06.097_bib0275","doi-asserted-by":"crossref","first-page":"316","DOI":"10.1128\/AAC.01302-08","article-title":"Susceptibility of Mycobacterium bovis BCG vaccine strains to antituberculous antibiotics","volume":"53","author":"Ritz","year":"2009","journal-title":"Antimicrob Agents Chemother"},{"issue":"3","key":"10.1016\/j.vaccine.2015.06.097_bib0280","first-page":"805","article-title":"WHO statement on BCG revaccination for the prevention of tuberculosis","volume":"73","year":"1995","journal-title":"Bull World Health Organ"},{"issue":"9493","key":"10.1016\/j.vaccine.2015.06.097_bib0285","doi-asserted-by":"crossref","first-page":"1290","DOI":"10.1016\/S0140-6736(05)67145-0","article-title":"Effect of BCG revaccination on incidence of tuberculosis in school-aged children in Brazil: the BCG-REVAC cluster-randomised trial","volume":"366","author":"Rodrigues","year":"2005","journal-title":"Lancet"},{"issue":"9019 (Jul 6)","key":"10.1016\/j.vaccine.2015.06.097_bib0290","first-page":"17","article-title":"Randomised controlled trial of single BCG, repeated BCG, or combined BCG and killed Mycobacterium leprae vaccine for prevention of leprosy and tuberculosis in Malawi","volume":"348","year":"1996","journal-title":"Lancet"},{"issue":"31 (Jul 12)","key":"10.1016\/j.vaccine.2015.06.097_bib0295","doi-asserted-by":"crossref","first-page":"4875","DOI":"10.1016\/j.vaccine.2011.05.023","article-title":"Evidence of an effect of BCG revaccination on incidence of tuberculosis in school-aged children in Brazil: second report of the BCG-REVAC cluster-randomised trial","volume":"29","author":"Barreto","year":"2011","journal-title":"Vaccine"},{"issue":"47 (Nov 5)","key":"10.1016\/j.vaccine.2015.06.097_bib0300","doi-asserted-by":"crossref","first-page":"5905","DOI":"10.1016\/j.vaccine.2008.08.061","article-title":"To BCG or not to BCG? Preventing travel-associated tuberculosis in children","volume":"26","author":"Ritz","year":"2008","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2015.06.097_bib0305","unstructured":"European Medicines Agency Guideline on good pharmacovigilance practices. 2014 [cited 11.03.15]; Available from: \u3008www.ema.europa.eu\/docs\/en_GB\/document_library\/Scientific_guideline\/2013\/05\/WC500143294.pdf\u3009."},{"key":"10.1016\/j.vaccine.2015.06.097_bib0310","unstructured":"World Health Organization Global Vaccine Safety:AEFI detection. 2014 [cited 11.03.15]; Available from: \u3008http:\/\/www.who.int\/vaccine_safety\/initiative\/detection\/en\/\u3009."},{"issue":"January (1)","key":"10.1016\/j.vaccine.2015.06.097_bib0315","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1007\/s40264-014-0248-6","article-title":"Bacillus Calmette-Guerin (BCG) vaccine adverse events in Victoria, Australia: analysis of reports to an enhanced passive surveillance system","volume":"38","author":"Clothier","year":"2015","journal-title":"Drug Saf"},{"issue":"24","key":"10.1016\/j.vaccine.2015.06.097_bib0320","doi-asserted-by":"crossref","first-page":"4059","DOI":"10.1016\/j.vaccine.2010.04.002","article-title":"Surveillance for adverse events following immunization (AEFI) in Switzerland\u20131991-2001","volume":"28","author":"Schumacher","year":"2010","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2015.06.097_bib0325","unstructured":"World Health Organization Global TB database. Available from: \u3008http:\/\/wwwwhoint\/tb\/country\/global_tb_database\/en\/indexhtml\u3009 2006 [cited 01.05.06];"},{"key":"10.1016\/j.vaccine.2015.06.097_bib0330","unstructured":"World Health Organization Global tuberculosis report 2014. 2014 [cited 04.12.14]; Available from: \u3008http:\/\/www.who.int\/tb\/publications\/global_report\/en\/\u3009."}],"container-title":["Vaccine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X15009147?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X15009147?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,8,27]],"date-time":"2019-08-27T20:41:00Z","timestamp":1566938460000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0264410X15009147"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,9]]},"references-count":33,"journal-issue":{"issue":"38","published-print":{"date-parts":[[2015,9]]}},"alternative-id":["S0264410X15009147"],"URL":"https:\/\/doi.org\/10.1016\/j.vaccine.2015.06.097","relation":{},"ISSN":["0264-410X"],"issn-type":[{"value":"0264-410X","type":"print"}],"subject":[],"published":{"date-parts":[[2015,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Current status of Bacille Calmette Gu\u00e9rin (BCG) immunisation in Europe \u2013 A ptbnet survey and review of current guidelines","name":"articletitle","label":"Article Title"},{"value":"Vaccine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.vaccine.2015.06.097","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2015 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}